Ranchoux et al. demonstrated that bacterial translocation occurs in PAH, suggesting a gut-lung cross-talk, in which TLR4 antagonists are plausible to be effective at disrupting this circle [141]. This evidence concerns the gene TLR4 and pulmonary arterial hypertension.